The FDA added a warning to the label of esketamine nasal spray (Spravato), noting that long-term cognitive and memory ...

"This data gives patients the option to benefit from esketamine treatment either with or without an antidepressant," said ...

An esketamine-based nasal spray antidepressant for adults is under review in the US following a filing from Johnson & Johnson's pharma unit. Janssen has submitted a filing for esketamine to the US ...

Esketamine for TRD demonstrated efficacy in reducing depressive symptoms and did not significantly differ based on TMS treatment history.

Results, published in CNS Spectrums, showed a significant improvement in symptoms for those taking a new OAD with esketamine ...

The US drugs regulator has approved the sale of a new nasal spray to treat depression. Manufacturer Janssen says Esketamine can lift a patient's mood within 24 hours of use. The drug is intended ...

When Dr. Husseini Manji was developing the first-in-class depression medication Spravato at Johnson & Johnson he encountered plenty of naysayers.

Janssen, which is Johnson & Johnson’s pharma unit, submitted a filing to the European Medicines Agency for esketamine nasal spray, which is designed to help people with treatment-resistant ...

Learn more about how an anesthetic traditionally used for surgical procedures may help depression and what to expect during ...

I specialize in using an array of treatment modalities, including medication management, psychoeducation, and interventional psychiatric approaches such as esketamine nasal treatment and TMS Therapy.

In addition, I apply interventional psychiatric approaches such as esketamine nasal treatment and transcranial magnetic stimulation (TMS) Therapy for treatment-resistant depression. Welcome— My ...